On Tuesday, Danaher Corp's (NYSE:DHR) second quarter sales decreased 3% year-over-year to $$5.743 billion, beating the consensus of $5.59 billion.  Non-GAAP core revenue decreased by 3.5%, compared to the expectations of a decline in the mid-single digits. Danaher reported second-quarter adjusted EPS of $1.72, beating the consensus of $1.57. Operating cash flow was $1.4 billion, and non-GAAP free cash flow was $1.1 billion. Rainer M. Blair, President and Chief Executive Officer, stated, "We were particularly pleased with the sustained positive momentum in our bioprocessing business and ...